Education

Timely Topics in Transplantation Webinar Series

November 18, 2014

Lara Danziger-Isakov, MD, MPH • Cincinnati Children's Hospital Medical Center
Deepali Kumar, MD, MSc, FRCPC • University Health Network
Moderated by Camille Kotton, MD • Massachusetts General Hospital

View Archive

Free to AST members: $25 fee is waived upon logging in during the checkout process.

Transplant clinicians strive to prevent infection, and vaccination provides an opportunity to expand this effort. The current recommendations for vaccination, innovative research, and opportunity for advancing these efforts will be discussed.

After participating in this webinar, the learner will be able to:

  1. Explore current pre- and post-transplant vaccination recommendations for pediatric and adult transplant candidates/recipients.
  2. Appraise recent vaccination studies in transplantation with a focus on live-vaccines and more recently approved vaccinations.
  3. Identify new opportunities for vaccination in transplantation that are emerging.

View Archive

Free to AST members: $25 fee is waived upon logging in during the checkout process.

Transplant clinicians strive to prevent infection, and vaccination provides an opportunity to expand this effort. The current recommendations for vaccination, innovative research, and opportunity for advancing these efforts will be discussed.

After participating in this webinar, the learner will be able to:

  1. Explore current pre- and post-transplant vaccination recommendations for pediatric and adult transplant candidates/recipients.
  2. Appraise recent vaccination studies in transplantation with a focus on live-vaccines and more recently approved vaccinations.
  3. Identify new opportunities for vaccination in transplantation that are emerging.
November 04, 2014

Gena Boyle, MPA • UNOS
Richard Formica, MD • Yale University
Moderated by Nicole Turgeon, MD • Emory University

View Archive

Free to AST members: $25 fee is waived upon logging in during the checkout process.

The new kidney allocation system is being implemented on December 4, 2014. Is your transplant program, OPO, and/or histocompatibility laboratory ready? During this webinar, the presenters will walk through the six major elements of the new kidney allocation system. For each element, the presenters will use screen shots and other illustrations to provide information on:

  • The essential preparations that transplant programs, histocompatibility laboratories, and OPOs need to take to prepare for implementation
  • How the UNOS computer system is currently programmed to assist transplant programs with preparing their list for December 4
  • How the new system will capture and use these new data elements
  • Helpful hints for complying with the new policy
  • Answers to frequently asked questions

After participating in this webinar, the learner will be able to:

  1. Describe the impact of upcoming policy and system changes related to the new kidney allocation system for patients and the transplant centers.
  2. Utilize tools and resources provided by the OPTN to prepare for system implementation for patients and the transplant centers.
  3. Identify methods for compliance with the new kidney allocation policies for transplant centers.

View Archive

Free to AST members: $25 fee is waived upon logging in during the checkout process.

The new kidney allocation system is being implemented on December 4, 2014. Is your transplant program, OPO, and/or histocompatibility laboratory ready? During this webinar, the presenters will walk through the six major elements of the new kidney allocation system. For each element, the presenters will use screen shots and other illustrations to provide information on:

  • The essential preparations that transplant programs, histocompatibility laboratories, and OPOs need to take to prepare for implementation
  • How the UNOS computer system is currently programmed to assist transplant programs with preparing their list for December 4
  • How the new system will capture and use these new data elements
  • Helpful hints for complying with the new policy
  • Answers to frequently asked questions

After participating in this webinar, the learner will be able to:

  1. Describe the impact of upcoming policy and system changes related to the new kidney allocation system for patients and the transplant centers.
  2. Utilize tools and resources provided by the OPTN to prepare for system implementation for patients and the transplant centers.
  3. Identify methods for compliance with the new kidney allocation policies for transplant centers.
December 12, 2016

View Archive

Speaker: Minnie Sarwal, MD, PhD, MRCP, DCH, FRCP • University of California San Francisco
Moderator: Julie Yabu, MD • Stanford University
 

After participating in this webinar, the learner will be able to:

  1. Identify potential biomarkers and assays for diagnosis for rejection and graft injury
  2. Describe the integration of bioinformatics and datasets in transplantation
  3. Design a strategy to prospectively manage transplant patients using biomarkers to preserve organ function

Moderator: Julie Yabu, MD

 

October 21, 2014

Christian Oberkofler, MDUniversity Hospital Zurich
Thomas Mueller, MD, PhDUniversity Hospital Zurich

View Archive

Free to AST members: $25 fee is waived upon logging in during the checkout process.

Whether you missed the World Transplant Congress or simply did not have time to catch all of the sessions, attend this webinar and get the important clinical highlights from the meeting.

After participating in this webinar, the learner will be able to:

  1. Describe the impact of novel methods of immune monitoring, antibody detection and immune phenotyping on individualized patient treatment
  2. Discuss living donor safety in respect to current publications and concerns
  3. Explain surgical innovations in the field of transplantation – organ perfusion systems, laparoscopic/robotic kidney and uterus transplantation

View Archive

Free to AST members: $25 fee is waived upon logging in during the checkout process.

Whether you missed the World Transplant Congress or simply did not have time to catch all of the sessions, attend this webinar and get the important clinical highlights from the meeting.

After participating in this webinar, the learner will be able to:

  1. Describe the impact of novel methods of immune monitoring, antibody detection and immune phenotyping on individualized patient treatment
  2. Discuss living donor safety in respect to current publications and concerns
  3. Explain surgical innovations in the field of transplantation – organ perfusion systems, laparoscopic/robotic kidney and uterus transplantation
November 17, 2016

View Archive

Speaker: Stephanie Pouch, MD • The Ohio State University Medical Center
Moderator: Shirish Huprikar, MD • Icahn School of Medicine at Mount Sinai

Multidrug-resistant organisms (MDROs) pose a particular threat to solid organ transplant recipients.  Infections due to these pathogens are associated with significant morbidity and mortality, and current therapeutic options are limited.  

After participating in this webinar, the learner will be able to:

  1. Describe the epidemiology and outcomes of select MDRO infections in solid organ transplant recipients.
  2. Describe an approach to the use of organs from donors colonized or infected with CRE.
  3. Discuss the role of infection control and antimicrobial stewardship in curtailing the spread of MDROs in solid organ transplant recipients. 
May 21, 2014

Read Q&A that wasn't answered during the webinar

 View Archive

Free to AST members: $25 fee is waived upon logging in during the checkout process.

Explore the relevance of HLA testing before and after transplant in solid organ transplantation. At the end of this webinar, participants will be able to:

  1. Understand the enhanced methods of HLA typing and antibody detection now available before transplant
  2. Gain insight in determining recipient humoral risk profiles before and after transplant based on available testing
  3. Appreciate the limitations of HLA testing and the importance of context in interpretation

Explore the relevance of HLA testing before and after transplant in solid organ transplantation.

At the end of this webinar, participants will be able to:

  • Understand the enhanced methods of HLA typing and antibody detection now available before transplant
  • Gain insight in determining recipient humoral risk profiles before and after transplant based on available testing
  • Appreciate the limitations of HLA testing and the importance of context in interpretation
November 15, 2016

View Archive

Speaker: Jignesh Patel, MD • Cedars-Sinai Heart Institute
Moderator: Monica Colvin, MD, MS • University of Michigan

The presence of donor specific antibodies predisposes the thoracic allograft to the risk of antibody mediated rejection, chronic graft dysfunction and increased mortality. Optimal outcomes depend upon a comprehensive understanding of the significance of circulating antibodies after transplantation.  What are the best strategies for defining deleterious antibodies, what are the current available therapies to address these and how effective are they?
 

After participating in this webinar, the learner will be able to:
  1. Identify the significance of circulating antibodies in patients awaiting thoracic transplantation or in patients with development of de novo antibodies after transplantation.
  2. Order appropriate tests to detect relevant donor specific antibodies.
  3. Design rational therapies for the treatment of post-thoracic transplant circulating antibodies.
April 23, 2014

View Archive

Read Q&A that was not answered during the webinar

Free to AST members: $25 fee is waived upon logging in during the checkout process.

Join a transplant nephrologist, transplant surgeon, and epidemiologist as they discuss the risk of ESRD in living kidney donors focusing on two recent publications in JAMA and Kidney International. The presenters will provide:

  • A brief overview of risks of living kidney donation known to date
  • Discussion of the study design, methods and statistics in the manuscripts
  • Implications of the manuscripts on living kidney donation and how to discuss risk with living donors in the context of this new information 

Links to manuscripts:

Join a transplant nephrologist, transplant surgeon, and epidemiologist as they discuss the risk of ESRD in living kidney donors focusing on two recent publications in JAMA and Kidney International. The presenters will provide:

  • A brief overview of risks of living kidney donation known to date
  • Discussion of the study design, methods and statistics in the manuscripts
  • Implications of the manuscripts on living kidney donation and how to discuss risk with living donors in the context of this new information
October 18, 2016

VIEW ARCHIVE
 

Read the Q&A that wasn't answered during webinar

Speaker: Peter Nickerson, MD, FRCPC, FCAHS • University of Manitoba
Moderator: Leonardo Riella, MD, PhD • Harvard Medical School

After participating in this webinar, the learner will be able to:

  1. Understand the use and limitations of solid phase assays in identifying anti-HLA antibodies
  2. Describe the natural history and significance of DSA development post-transplant
  3. Discuss novel tools to improve specificity of solid phase assays 
March 19, 2014

View Archive

Free to AST members: $25 fee is waived upon logging in during the checkout process.

What you'll learn:

  1. Describe the common targets for direct acting antiviral therapy for HCV
  2. Understand current side effects and cure rates to therapy for HCV in liver transplant patients
  3. Discuss all oral DAA drug cocktails for HCV that can and will be used in the near future in transplant patients

What you'll learn:

  • Describe the common targets for direct acting antiviral therapy for HCV
  • Understand current side effects and cure rates to therapy for HCV in liver transplant patients
  • Discuss all oral DAA drug cocktails for HCV that can and will be used in the near future in transplant patients

Pages